The IPO 4-1-1: Four fil­ings, a pric­ing and a with­draw­al head­line this week's Nas­daq ac­tion as raise ap­proach­es $7.5B

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

An­oth­er week, an­oth­er horde of biotechs is do­ing the Nas­daq dance.

This week saw four com­pa­nies file their SEC pa­per­work ahead of ex­pect­ed de­buts, an­oth­er hit Nas­daq on Fri­day and a sixth for­mal­ly with­drew its bid to go pub­lic. Aerovate Ther­a­peu­tics, Ocean Bio­med­ical and Acu­men Phar­ma­ceu­ti­cals all pen­ciled in ini­tial rais­es of $100 mil­lion, while Der­ma­ta Ther­a­peu­tics is es­ti­mat­ing a mod­est $18 mil­lion raise.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.